Business Context and Reporting Period
Company: HealthSouth Corporation (filing as HealthSouth Corporation; note: metadata referenced Encompass Health, but filing text confirms HealthSouth).
Reporting Period: Quarterly period ended June 30, 2009 (Form 10-Q).
Business Overview: The nation's largest provider of inpatient rehabilitative healthcare services, operating 93 inpatient rehabilitation hospitals, 6 long-term acute care hospitals, and various outpatient facilities across 26 states and Puerto Rico. The company is heavily regulated, with Medicare comprising approximately 68% of net operating revenues.
Key Financial Metrics (Six Months Ended June 30, 2009)
| Metric | Amount (in millions) |
|---|---|
| Net Operating Revenues | $958.8 |
| Net Income | $57.1 |
| Net Income Attributable to HealthSouth | $39.4 |
| Net Income Attributable to Common Shareholders | $26.4 |
| Adjusted Consolidated EBITDA | $192.7 |
| Net Cash Provided by Operating Activities | $229.2 |
| Total Debt Outstanding | $1,701.9 |
| Cash and Cash Equivalents | $49.8 |
| Restricted Cash and Securities | $92.9 |
Margins: Operating expenses totaled $828.8 million (86.4% of revenues). Salaries and benefits represented 49.4% of net operating revenues.
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 4.1% year-over-year to $958.8 million, driven by a 5.6% increase in inpatient discharges.
- Profitability Decline: Net income attributable to HealthSouth common shareholders decreased significantly from $50.9 million in the prior year to $26.4 million. This was primarily due to a $32.8 million charge for government/class action settlements (compared to a $45.0 million gain in the prior year) and a $28.5 million gain on interest rate swaps in the prior year that was not repeated.
- Debt Reduction: Total debt was reduced by approximately $111 million during the six-month period, utilizing cash from operations, a federal income tax refund, and proceeds from the UBS litigation settlement.
- Interest Expense: Interest expense decreased 27.9% to $65.5 million due to lower average borrowings and a decrease in the average interest rate (7.1% vs. 8.9% in the prior year).
Guidance, Outlook, and Risks
Management Outlook: Management expects demand for inpatient rehabilitation to grow due to an aging population. The primary strategic focus remains on deleveraging the balance sheet. The company anticipates generating cash flows to fund further debt reduction and disciplined development activities.
Key Risks and Contingencies:
- Legal Settlements: The company faces significant volatility in earnings due to the fair value adjustments of the securities litigation settlement liability, which is tied to the company's stock price. A $48.6 million increase in this liability was recorded in Q2 2009.
- Regulatory Environment: The company is subject to a Medicare pricing "roll-back" effective through September 30, 2009. Future healthcare reform legislation could impact reimbursement rates (market basket updates) or introduce bundled payment systems.
- Litigation: A $2.9 billion judgment was awarded against former CEO Richard Scrushy in June 2009; however, collectibility is uncertain. Arbitration with former auditor Ernst & Young remains pending.
- Liquidity: While the company is in compliance with credit covenants (leverage ratio improved to 4.7x), it maintains a high debt load. The revolving credit facility ($400 million) is undrawn and available.
Investor Verification Checklist
- Settlement Liability Volatility: Verify the current fair value of the securities litigation settlement liability and its sensitivity to stock price fluctuations, as this creates significant non-cash earnings volatility.
- Debt Covenant Compliance: Confirm continued compliance with the leverage and interest coverage ratios in the Credit Agreement, especially given the high debt load relative to EBITDA.
- Scrushy Judgment Collectibility: Assess the likelihood of collecting the $2.9 billion judgment against Richard Scrushy, as this is not currently recognized in financial statements.
- Medicare Reimbursement Trends: Monitor the impact of the Medicare pricing roll-back expiration in late 2009 and potential legislative changes to market basket updates.
- Discontinued Operations: Review the status of the pending transfer of the final surgery center facility to ASC Acquisition LLC, which could result in an additional gain of $10-$16 million upon approval.